Advanced Enzymes Technologies’ board has approved the investment of an amount not exceeding Rs 316.26 million by way of subscription to the issue of 492,630 equity shares of SciTech Specialties (SSPL), as may be offered on preferential issue / private placement basis by SSPL and purchase of 27,778 from selling shareholders of SSPL, aggregating to 520,408 equity shares i.e. 51% of equity share capital of SSPL and authorization for signing of Share Subscription and Shareholders' Agreement in this regard. On completion of the aforesaid investment, SSPL will become subsidiary of the company. The Board of Directors of the company in its meeting held on December 26, 2020 has approved the same.
Advanced Enzymes Technologies is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1660.35 |
| Dr. Reddys Lab | 1220.80 |
| Cipla | 1236.00 |
| Zydus Lifesciences | 928.80 |
| Lupin | 2313.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: